Literature DB >> 1540179

A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein.

N R Pumford1, B M Martin, J A Hinson.   

Abstract

Acetaminophen is metabolized by cytochrome P450 to a reactive metabolite that covalently binds to proteins and this binding correlates with the hepatotoxicity. The major protein adduct was previously reported to be a 55 kDa protein that was detected on Western blots using antisera specific for 3-(cystein-S-yl)acetaminophen. In this study, the 55 kDa protein was isolated using a combination of ion exchange fast flow chromatography, hydroxyapatite HPLC and anion exchange HPLC. Amino acid sequences of 8 internal peptides from a trypsin digestion of the 55 kDa protein were found to have 97% homology with the deduced amino acid sequence from a cDNA that corresponds to a 56 kDa selenium binding protein. This is the first report of a specific protein to which a metabolite of acetaminophen covalently binds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540179     DOI: 10.1016/0006-291x(92)91881-p

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.

Authors:  S Gupta; L K Rogers; S K Taylor; C V Smith
Journal:  Toxicol Appl Pharmacol       Date:  1997-10       Impact factor: 4.219

2.  Evidence for cellular protein covalent binding derived from styrene metabolite.

Authors:  Wei Yuan; Hua Jin; Jou-Ku Chung; Jiang Zheng
Journal:  Chem Biol Interact       Date:  2010-05-12       Impact factor: 5.192

3.  Genes encoding the acetaminophen and selenium binding proteins map to mouse chromosome 3.

Authors:  C L Navarro; S D Cohen; E A Khairallah
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

Review 4.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Proteomic analysis of acetaminophen-induced changes in mitochondrial protein expression using spectral counting.

Authors:  Brendan D Stamper; Isaac Mohar; Terrance J Kavanagh; Sidney D Nelson
Journal:  Chem Res Toxicol       Date:  2011-02-18       Impact factor: 3.739

Review 6.  Filling and mining the reactive metabolite target protein database.

Authors:  Robert P Hanzlik; Jianwen Fang; Yakov M Koen
Journal:  Chem Biol Interact       Date:  2008-09-06       Impact factor: 5.192

7.  The expression of selenium-binding protein 1 is decreased in uterine leiomyoma.

Authors:  Peng Zhang; Cunxian Zhang; Xudong Wang; Fang Liu; C James Sung; M Ruhul Quddus; W Dwayne Lawrence
Journal:  Diagn Pathol       Date:  2010-12-09       Impact factor: 2.644

8.  Ablation of Selenbp1 Alters Lipid Metabolism via the Pparα Pathway in Mouse Kidney.

Authors:  Yingxia Song; Atsushi Kurose; Renshi Li; Tomoki Takeda; Yuko Onomura; Takayuki Koga; Junpei Mutoh; Takumi Ishida; Yoshitaka Tanaka; Yuji Ishii
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 9.  Potential Role of Selenoenzymes and Antioxidant Metabolism in relation to Autism Etiology and Pathology.

Authors:  Laura J Raymond; Richard C Deth; Nicholas V C Ralston
Journal:  Autism Res Treat       Date:  2014-03-05

Review 10.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.